| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.47 | 0.009 |